Loscalzo Joseph's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Mar 5, 2026
- Accession no.
- 0000874015-26-000138
- Filed
- Mar 5, 2026
- Trade date
- Mar 3-4, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $82.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Loscalzo JosephCIK 0001276128 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Common Stock | MOption exerciseAcquired | +832 | $38.06 | +$31,665.92 | 37,162 | Direct | |
| Mar 3, 2026 | Common Stock | SSaleDisposed | −832 | $80.33 | −$66,834.56 | 36,330 | Direct | |
| Mar 4, 2026 | Common Stock | MOption exerciseAcquired | +200 | $38.06 | +$7,612 | 36,530 | Direct | |
| Mar 4, 2026 | Common Stock | SSaleDisposed | −200 | $80.00 | −$16,000 | 36,330 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Common Stock | MOption exerciseDisposed | −832 | $0.00 | $0 | 11,168 | Direct | |
| Mar 4, 2026 | Common Stock | MOption exerciseDisposed | −200 | $0.00 | $0 | 10,968 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.